Article
The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines
1 Jan 2019
Abstract excerpt
One of the factors promoting tumoral progress is the abnormal activation of the epithelial-mesenchymal transition (EMT) program which has been associated with chemoresistance in tumoral cells. The transcription factor zinc finger E-box-binding homeobox 1 (ZEB1), a key EMT activator, has recently been related to docetaxel resistance, the main chemotherapeutic used in advanced prostate cancer treatment. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
